Alginate encapsulation of human embryonic stem cells to enhance directed differentiation to pancreatic islet-like cells

Tissue Engineering - Part A

Volumn 20, Issue 23-24, 2014, Pages 3198-3211

  Richardson, Thomas ^a   Kumta, Prashant N ^a   Banerjee, Ipsita ^a  

^a University of Pittsburgh   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINATE; BIOSYNTHESIS; PEPTIDES; SIGNAL TRANSDUCTION; STEM CELLS;

ALGINATE ENCAPSULATION; DEGENERATIVE DISEASE; DIFFERENT STAGES; DIRECTED DIFFERENTIATIONS; HUMAN EMBRYONIC STEM CELLS; PANCREATIC ISLET; SIGNALING MOLECULES; SIGNALING PATHWAYS;

CYTOLOGY;

ALGINIC ACID; C PEPTIDE; GLUCOSE; PROTEIN KINASE B; SMAD PROTEIN; GLUCURONIC ACID; HEXURONIC ACID;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL SUSPENSION; CELL VIABILITY; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; PANCREAS ISLET CELL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; PANCREAS ISLET;

ALGINATES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; EMBRYONIC STEM CELLS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; ISLETS OF LANGERHANS;

EID: 84915763217     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0659     Document Type: Article

References (47)

1. Daneman, D. Type 1 diabetes. Lancet 367, 847, 2006.
2. Shapiro, A.M.J., Lakey, J.R.T., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoidfree immunosuppressive regimen. N Engl J Med 343, 230, 2000.
3. Lanza, R.P., Borland, K.M., Staruk, J.E., Appel, M.C., Solomon, B.A., and Chick, W.L. Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression. Endocrinology 131, 637, 1992.
4. O'Shea, G.M., Goosen, M.F.A., and Sun, A.M. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta (BBA) 804, 133, 1984.
5. Maki, T., Otsu, I., O'Neil, J.J., Dunleavy, K., Mullon, C.J., Solomon, B.A., et al. Treatment of diabetes by xenogeneic islets without immunosuppression: use of a vascularized bioartificial pancreas. Diabetes 45, 342, 1996.
6. Iwata, H., Amemiya, H., Matsuda, T., Takano, H., Hayashi, R., and Akutsu, T. Evaluation of microencapsulated islets in agarose-gel as bioartificial pancreas by studies of hormonesecretion in culture and by xenotransplantation. Diabetes 38, 224, 1989.
7. Lee, K.Y., and Mooney, D.J. Alginate: properties and biomedical applications. Prog Polym Sci 37, 106, 2012.
8. Leung, A., Nielsen, L.K., Trau, M., and Timmins, N.E. Tissue transplantation by stealth-coherent alginate microcapsules for immunoisolation. Biochem Eng J 48, 337, 2010.
9. Shen, F., Mazumder, M.A., Burke, N.A., Stover, H.D., and Potter, M.A. Mechanically enhanced microcapsules for cellular gene therapy. J Biomed Mater Res B Appl Biomater 90, 350, 2009.
10. Hillberg, A.L., Kathirgamanathan, K., Lam, J.B., Law, L.Y., Garkavenko, O., and Elliott, R.B. Improving alginatepoly-L-ornithine-alginate capsule biocompatibility through genipin crosslinking. J Biomed Mater Res B Appl Biomater 101, 258, 2013.
11. O'Sullivan, E., Johnson, A., Omer, A., Hollister-Lock, J., Bonner-Weir, S., Colton, C., et al. Rat islet cell aggregates are superior to islets for transplantation in microcapsules. Diabetologia 53, 937, 2010.
12. Lim, F., and Sun, A. Microencapsulated islets as bioartifi-cial endocrine pancreas. Science 210, 908, 1980.
13. Oshea, G.M., and Sun, A.M. Encapsulation of rat islets of langerhans prolongs xenograft survival in diabetic mice. Diabetes 35, A82, 1986.
14. Duvivier-Kali, V.F., Omer, A., Parent, R.J., O'Neil, J.J., and Weir, G.C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50, 1698, 2001.
15. Hoesli, C.A., Kiang, R.L.J., Mocinecová, D., Speck, M., Mosková, D.J., Donald-Hague, C., et al. Reversal of diabetes by bTC3 cells encapsulated in alginate beads generated by emulsion and internal gelation. J Biomed Mater Res B Appl Biomater 100B, 1017, 2012.
16. Scharp, D.W., and Marchetti, P. Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv Drug Deliv Rev 67-68, 35, 2014.
17. Steele, J.A.M., Hallé, J.P., Poncelet, D., and Neufeld, R.J. Therapeutic cell encapsulation techniques and applications in diabetes. Adv Drug Deliv Rev 67-68, 74, 2014.
18. Dufrane, D., Goebbels, R.M., Saliez, A., Guiot, Y., and Gianello, P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 81, 1345, 2006.
19. Tuch, B.E., Keogh, G.W., Williams, L.J., Wu, W., Foster, J.L., Vaithilingam, V., et al. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 32, 1887, 2009.
20. Balamurugan, A.N., Bottino, R., Giannoukakis, N., and Smetanka, C. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes. Pancreas 32, 231, 2006.
21. Segev, H., Fishman, B., Ziskind, A., Shulman, M., and Itskovitz-Eldor, J. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 22, 265, 2004.
22. Xu, X., Kahan, B., Forgianni, A., Jing, P., Jacobson, L., Browning, V., et al. Endoderm and pancreatic islet lineage differentiation from human embryonic stem cells. Cloning Stem Cells 8, 96, 2006.
23. Baharvand, H., Jafary, H., Massumi, M., and Ashtiani, S.K. Generation of insulin-secreting cells from human embryonic stem cells. Dev Growth Differ 48, 323, 2006.
24. D'Amour, K.A., Bang, A.G., Eliazer, S., Kelly, O.G., Agulnick, A.D., Smart, N.G., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24, 1392, 2006.
25. Maguire, T., Novik, E., Schloss, R., and Yarmush, M. Alginate-PLL microencapsulation: Effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol Bioeng 93, 581, 2006.
26. Li, L., Davidovich, A.E., Schloss, J.M., Chippada, U., Schloss, R.R., Langrana, N.A., et al. Neural lineage differentiation of embryonic stem cells within alginate microbeads. Biomaterials 32, 4489, 2011.
27. Wang, N., Adams, G., Buttery, L., Falcone, F.H., and Stolnik, S. Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells. J Biotechnol 144, 304, 2009.
28. Siti-Ismail, N., Bishop, A.E., Polak, J.M., and Mantalaris, A. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 29, 3946, 2008.
29. Chayosumrit, M., Tuch, B., and Sidhu, K. Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. Biomaterials 31, 505, 2010.
30. Dean, S.K., Yulyana, Y., Williams, G., Sidhu, K.S., and Tuch, B.E. Differentiation of encapsulated embryonic stem cells after transplantation. Transplantation 82, 1175, 2006.
31. Kim, J., Sachdev, P., and Sidhu, K. Alginate microcapsule as a 3D platform for the efficient differentiation of human embryonic stem cells to dopamine neurons. Stem Cell Res 11, 978, 2013.
32. Jaramillo, M., and Banerjee, I. Endothelial cell co-culture mediates maturation of human embryonic stem cell to pancreatic insulin producing cells in a directed differentiation approach. J Vis Exp pii: 3759, 2012.
33. Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25, 681, 2007.
34. Heiligenstein, S., Cucchiarini, M., Laschke, M.W., Bohle, R.M., Kohn, D., Menger, M.D., et al. In vitro and in vivo characterization of nonbiomedical-and biomedical-grade alginates for articular chondrocyte transplantation. Tissue Eng Part C Methods 17, 829, 2011.
35. Thomas, F.T., Contreras, J.L., Bilbao, G., Ricordi, C., Curiel, D., and Thomas, J.M. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery 126, 299, 1999.
36. Rezania, A., Bruin, J.E., Riedel, M.J., Mojibian, M., Asadi, A., Xu, J., et al. Maturation of human embryonic stem cellderived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 61, 2016, 2012.
37. Bruin, J.E., Rezania, A., Xu, J., Narayan, K., Fox, J.K., O'Neil, J.J., et al. Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice. Diabetologia 56, 1987, 2013.
38. Cozar-Castellano, I., Fiaschi-Taesch, N., Bigatel, T.A., Takane, K.K., Garcia-Ocanã, A., Vasavada, R., et al. Molecular control of cell cycle progression in the pancreatic b-Cell. Endocr Rev 27, 356, 2006.
39. Tuch, B.E., Hughes, T.C., and Evans, M.D. Encapsulated pancreatic progenitors derived from human embryonic stem cells as a therapy for insulin-dependent diabetes. Diabetes Metab Res Rev 27, 928, 2011.
40. Mart?n, F., Andreu, E., Rovira, J.M., Pertusa, J.A., Raurell, M., Ripoll, C., et al. Mechanisms of glucose hypersensitivity in beta-cells from normoglycemic, partially pancreatectomized mice. Diabetes 48, 1954, 1999.
41. Ungrin, M.D., Joshi, C., Nica, A., Bauwens, C., and Zandstra, P.W. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspensionderived human embryonic stem cell aggregates. PLoS One 3, e1565, 2008.
42. Nair, R., Ngangan, A.V., Kemp, M.L., and McDevitt, T.C. Gene expression signatures of extracellular matrix and growth factors during embryonic stem cell differentiation. PLoS One 7, e42580, 2012.
43. Brafman, D.A., Phung, C., Kumar, N., and Willert, K. Regulation of endodermal differentiation of human embryonic stem cells through integrin-ECM interactions. Cell Death Differ 20, 369, 2013.
44. Jones, L.E., Humphreys, M.J., Campbell, F., Neoptolemos, J.P., and Boyd, M.T. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 10, 2832, 2004.
45. Singh, A.M., Reynolds, D., Cliff, T., Ohtsuka, S., Mattheyses, A.L., Sun, Y.H., et al. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 10, 312, 2012.
46. Conery, A.R., Cao, Y.N., Thompson, E.A., Townsend, C.M., Ko, T.C., and Luo, K.X. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta-induced apoptosis. Nat Cell Biol 6, 366, 2004.
47. Remy, I., Montmarquette, A., and Michnick, S.W. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol 6, 358, 2004.